Temsirolimus and Cixutumumab in Treating Patients With Locally Advanced, Metastatic, or Recurrent Soft Tissue Sarcoma or Bone Sarcoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
24 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Cross Cancer Institute
Edmonton, Alberta, Canada
- University Health Network-Princess Margaret Hospital
Toronto, Ontario, Canada
- Ucla / Jonsson Comprehensive Cancer Center
Los Angeles, California, United States
- Mayo Clinic in Florida
Jacksonville, Florida, United States
- Moffitt Cancer Center
Tampa, Florida, United States
- Northwestern University
Chicago, Illinois, United States
- University of Chicago Comprehensive Cancer Center
Chicago, Illinois, United States
- Decatur Memorial Hospital
Decatur, Illinois, United States
- Northshore University Healthsystem-Evanston Hospital
Evanston, Illinois, United States
- Memorial Medical Center
Springfield, Illinois, United States
- University of Maryland/greenebaum Cancer Center
Baltimore, Maryland, United States
- University of Michigan
Ann Arbor, Michigan, United States
- University of Michigan University Hospital
Ann Arbor, Michigan, United States
- Mayo Clinic
Rochester, Minnesota, United States
- Memorial Sloan-Kettering Cancer Center
New York, New York, United States
- Suny College at Old Westbury
Old Westbury, New York, United States
- Albert Einstein College of Medicine
The Bronx, New York, United States
- Montefiore Medical Center - Moses Campus
The Bronx, New York, United States
- Carolinas Medical Center
Charlotte, North Carolina, United States
- Fox Chase Cancer Center
Philadelphia, Pennsylvania, United States
- Medical University of South Carolina
Charleston, South Carolina, United States
- Vanderbilt-Ingram Cancer Center
Nashville, Tennessee, United States
- M D Anderson Cancer Center
Houston, Texas, United States
- Virginia Commonwealth University/massey Cancer Center
Richmond, Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Nov 2009
- Primary completion
- 31 Jul 2014
- Completion
- 31 Jul 2014
- Last update posted
- 30 Jul 2015
- Registered enrollment
- 178
- Registry id
- NCT01016015
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.